⌘K

Home/Filings/4/0001567619-19-007665

4//SEC Filing

Paccasassi Robert 4

Accession 0001567619-19-007665

CIK 0001505497other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 5:23 PM ET

Size

20.5 KB

Accession

0001567619-19-007665

Insider Transaction Report

Form 4

Period: 2019-03-25

BioRestorative Therapies, Inc.BRTX

Paccasassi Robert

VP, Quality and Compliance

Transactions

Disposition to Issuer
Stock Option
2019-03-25−5,000→ 0 total
Exercise: $4.70Exp: 2025-08-13→ Common Stock (5,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−15,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (15,000 underlying)
Award
Stock Option
2019-03-25+15,000→ 15,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−40,000→ 0 total
Exercise: $2.80Exp: 2027-07-12→ Common Stock (40,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−50,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (50,000 underlying)
Award
Stock Option
2019-03-25+40,000→ 40,000 total
Exercise: $0.75Exp: 2027-07-12→ Common Stock (40,000 underlying)
Award
Stock Option
2019-03-25+50,000→ 50,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (50,000 underlying)
Award
Stock Option
2019-03-25+5,000→ 5,000 total
Exercise: $0.75Exp: 2025-08-13→ Common Stock (5,000 underlying)

Footnotes (5)

[F1]The option is exercisable to the extent of 1,667 shares on each of August 13, 2016 and August 13, 2017, and 1,666 shares on August 13, 2018.
[F2]The option is exercisable to the extent of 5,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019.
[F3]The option is exercisable to the extent of 13,334 shares on July 12, 2018, and 13,333 shares on each of July 12, 2019 and July 12, 2020.
[F4]The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021.
[F5]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1

filerCIK 0001751339

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 5:23 PM ET
Size: 20.5 KB

View on SEC.gov